Blog

Posted:

Waystar makes $1.25B bet on AI for healthcare payments

Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities. Read more here.

Read more: Waystar makes $1....
Posted:

NICE approves new treatment for inflammatory bowel disease

Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS. Read more here.

Read more: NICE approves new...
Posted:

Scientists discover eight new schizophrenia genes

The breakthrough, made by scientists at the Centre for Neuropsychiatric Genetics and Genomics (CNGG) at Cardiff University, provides new information and improves the understanding and future treatment development for schizophrenia. Read more here.  

Read more: Scientists discov...
Posted:

Quarter of junior doctors work part-time

In a survey of 50,000 junior doctors, now officially known as resident doctors, 24 per cent said they opted to work “less than full-time”. The average full-time hours are 40 to 48 hours per week. Read more here.

Read more: Quarter of junior...
Posted:

WY ICB Distinguished Lecture Series - The Future of Digital Health

Health Innovation Yorkshire & Humber are proud to launch the Distinguished Lecture Series - as part of the Digital, Data, Technology and AI Literacy Programme, a partnership between @WYPartnership and West Yorkshire Innovation Hub. Date: Mon 22 Sept, 12:00 pm. Read…

Read more: WY ICB Distinguis...
Posted:

Avoiding Pitfalls in Healthcare Capital Planning

Capital planning in healthcare is not merely an administrative obligation—it is a strategic discipline that shapes clinical capabilities, operational resilience and financial health.  Recognising and addressing common planning mistakes is essential to sustaining high-quality, efficient care in an increasingly complex…

Read more: Avoiding Pitfalls...
Posted:

Bye bye, bifocals? New eye drops can fix farsightedness

The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of…

Read more: Bye bye, bifocals...
Posted:

Gates Foundation pledges $2.5B to women’s health research

The Gates Foundation said it is committing to invest $2.5 billion over the next five years to accelerate research and development in neglected areas of women’s health.  Lack of investment often slows the research necessary for biotechnology companies to develop new medicines,…

Read more: Gates Foundation ...
Posted:

OpenAI's Sam Altman touts benefit of GPT-5 for healthcare

OpenAI released its most advanced reasoning model, GPT-5, which it touts as its most useful model for healthcare. Read more here.

Read more: OpenAI's Sam Altm...
Posted:

Ascension launches new Clinical Innovation Institute to vet leading-edge IT

St. Louis-based Ascension this week announced its new Clinical Innovation Institute, designed as a center of excellence devoted to vetting emerging technologies and harnessing that innovation for enterprise-wide growth, quality improvement, and improved patient and provider experience. Read more here.

Read more: Ascension launche...
Posted:

Korea, Singapore harness AI to drive GI cancer detection, prediction

New AI-driven systems for detecting and predicting gastrointestinal cancers have been developed through research projects in Singapore and South Korea. Read more here.

Read more: Korea, Singapore ...
Posted:

Artificial intelligence is revolutionizing medical image analysis

AI is showing up in our lives more prominently than ever, with the arrival of ChatGPT and other chatbots. The latest version of ChatGPT, for instance, incorporates visual-language models (VLM) which add visual understanding on top of the LLM's language skills. …

Read more: Artificial intell...